Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

NCT00440726 is registered in ClinicalTrials.gov with Therapeutic Advances in Childhood Leukemia Consortium as lead sponsor.

NCT NCT00440726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
Lead sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
August 4, 2006
Completion date
February 26, 2011
Enrollment
31 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia